郑敏

郑敏 (chief executive) discloses dealings in 康泰医学 to SSE / SZSE (CSRC). In total, 3 filings cover trades dated from 27 September 2021 to 14 March 2022.

The open-market record consists of 3 sales worth €1.8M, with no purchase. 2022 to date brings no purchases and 1 sale.

On 14 March 2022 came the latest disclosure, an open-market sale for €910k in 康泰医学. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.